Concepedia

Lifang Yin

LY

Statistics

Publications

83

Citations

3.7K

H-Index

39

Active since

2011

Affiliations

China Pharmaceutical University(Current)

National Medical Products Administration

State Key Laboratory of Natural Medicine

Peking University

Lifang Yin is an author at China Pharmaceutical University specializing in drug delivery, pharmacy, and pharmaceutics.

ORCID

Publications per year

2011–2024

83

Publications

83

Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells

Yaqi Lv, Chaoran Xu, Xiangmei Zhao et al. · ACS Nano · 2018 · 230 citations

, , +17

Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer

Tingjie Yin, Lei Wang, Lifang Yin et al. · Biomaterials · 2015 · 169 citations

, , +17

Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel

Xiaoying Wang, Yihang Chen, Fatima Zohra Dahmani et al. · Biomaterials · 2014 · 161 citations

, , +16

Targeting intracellular MMPs efficiently inhibits tumor metastasis and angiogenesis

Yaqi Lv, Xiangmei Zhao, Lidan Zhu et al. · Theranostics · 2018 · 113 citations · Full text

, , +17

Insulin-Loaded pH-Sensitive Hyaluronic Acid Nanoparticles Enhance Transcellular Delivery

Lina Han, Yuefang Zhao, Lifang Yin et al. · AAPS PharmSciTech · 2012 · 106 citations · Full text

, , +10

1–5 of 83